Smaller models, lightweight frameworks, specialized hardware, and other innovations are bringing AI out of the cloud and into ...

Targets readouts from nine ongoing Phase 2 and Phase 3 clinical studies in its oncology pipeline, including three Phase 3 programs for intismeran autogene Further improves 2026 and 2027 expected GAAP ...

Industry-focused artificial intelligence, growing adoption of agentic systems and edge AI, “born in the AI era” cyberattacks ...